Li, Yuqing <br/><br/>
Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer.  [electronic resource] 

 -  Breast cancer research : BCR  Jan 2011 
 - R10 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1465-542X 
<br/><br/><label>Standard No.: </label>10.1186/bcr2817  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Breast Neoplasms--genetics<br/>Carrier Proteins--genetics<br/>Case-Control Studies<br/>Epistasis, Genetic<br/>Estrogen Receptor alpha--genetics<br/>Female<br/>Finland<br/>Genetic Predisposition to Disease<br/>Genotype<br/>Humans<br/>Middle Aged<br/>Polymorphism, Single Nucleotide<br/>RNA-Binding Proteins<br/>Risk Assessment<br/>Sweden<br/>Transcription, Genetic